cancer screening
Sema4, Avera Health Collaborate on Precision Oncology Program
The partnership, which will start with oncology, will introduce Sema4's genomic testing and Centrellis health intelligence technology to Avera's clinical and research programs.
Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data
Premium
The company presented its first analyses answering crucial questions about real-world performance and impact on patients' well-being and healthcare utilization.
Recent results from the firm's case-control study cohort showed overall sensitivity of about 50 percent but higher performance for a subset of high-mortality cancers.
The results represent a significant improvement over currently used screening tools and are spurring renewed LDT commercialization and regulatory submission efforts.
CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test
CellMax also completed a Series C financing round to speed up development of itsFirstSight liquid biopsy test to detect colorectal cancer and precancer polyps.